SEC (Securities and Exchange Commission) launches formal investigation into PolyMedica
This article was originally published in Clinica
Executive Summary
The US Securities and Exchange Commission (SEC) has issued a formal order of investigation to PolyMedica. The company's Liberty Medical diabetes supply subsidiary is already under investigation by the FBI for fraud. Shares in PolyMedica fell 22% to $19.